miRNAs: EBV Mechanism for Escaping Host’s Immune Response and Supporting Tumorigenesis
Snježana Židovec Lepej,Maja Matulić,Paula Gršković,Mirjana Pavlica,Leona Radmanić,Petra Korać
DOI: https://doi.org/10.3390/pathogens9050353
IF: 3.7
2020-05-08
Pathogens
Abstract:Epstein-Barr virus (EBV) or human herpesvirus 4 (HHV-4) is a ubiquitous human oncogenic virus, and the first human virus found to express microRNAs (miRNAs). Its genome contains two regions encoding more than 40 miRNAs that regulate expression of both viral and human genes. There are numerous evidences that EBV miRNAs impact immune response, affect antigen presentation and recognition, change T- and B-cell communication, drive antibody production during infection, and have a role in cell apoptosis. Moreover, the ability of EBV to induce B-cell transformation and take part in mechanisms of oncogenesis in humans is well known. Although EBV infection is associated with development of various diseases, the role of its miRNAs is still not understood. There is abundant data describing EBV miRNAs in nasopharyngeal carcinoma and several studies that have tried to evaluate their role in gastric carcinoma and lymphoma. This review aims to summarize so far known data about the role of EBV miRNAs in altered regulation of gene expression in human cells in EBV-associated diseases.
microbiology
What problem does this paper attempt to address?